Skip to main content
  • Notice of Privacy Incident
  • Medicaid Provider Termination Alert: Revalidation deadlines are approaching. Failure by providers to revalidate will lead to termination and payment suspension. Check your account now at https://impact.illinois.gov/ to learn if your required revalidation is due this month. More revalidation information here.

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: September 14, 2016

Drugs and Therapeutics (D & T) Committee

Drugs Under Review for:

September 14, 2016

Drug Name Review Type Class Manufacturer
Viekira HR New Drug Initial Review Hepatitis C AbbVie
Ocaliva New Drug Initial Review Primary Biliary Cholangitis Intercept Pharmaceuticals
Briviact New Drug Initial Review Anticonvulsant UCB, Inc.
Epclusa New Drug Initial Review Hepatitis C Gilead Sciences
Xtampza ER New Drug Initial Review Extended Release Opioid Collegium Pharmaceutical
Spinosad New Drug Initial Review Lice Treatment ParaPro
Adzenys XR-ODT New Drug Initial Review Stimulant Neos Therapeutics
Orenitram New Drug Appeal Pulmonary Arterial Hypertension United Therapeutics